11 research outputs found
SERS Detection of Amyloid Oligomers on Metallorganic-Decorated Plasmonic Beads
Protein
misfolded proteins are among the most toxic endogenous species of
macromolecules. These chemical entities are responsible for neurodegenerative
disorders such as Alzheimer’s, Parkinson’s, Creutzfeldt–Jakob’s
and different non-neurophatic amyloidosis. Notably, these oligomers
show a combination of marked heterogeneity and low abundance in body
fluids, which have prevented a reliable detection by immunological
methods so far. Herein we exploit the selectivity of proteins to react
with metallic ions and the sensitivity of surface-enhanced Raman spectroscopy
(SERS) toward small electronic changes in coordination compounds to
design and engineer a reliable optical sensor for protein misfolded
oligomers. Our strategy relies on the functionalization of Au nanoparticle-decorated
polystyrene beads with an effective metallorganic Raman chemoreceptor,
composed by Al<sup>3+</sup> ions coordinated to 4-mercaptobenzoic
acid (MBA) with high Raman cross-section, that selectively binds aberrant
protein oligomers. The mechanical deformations of the MBA phenyl ring
upon complexation with the oligomeric species are registered in its
SERS spectrum and can be quantitatively correlated with the concentration
of the target biomolecule. The SERS platform used here appears promising
for future implementation of diagnostic tools of aberrant species
associated with protein deposition diseases, including those with
a strong social and economic impact, such as Alzheimer’s and
Parkinson’s diseases
Toxicity of Protein Oligomers Is Rationalized by a Function Combining Size and Surface Hydrophobicity
The misfolding and aberrant assembly
of peptides and proteins into
fibrillar aggregates is the hallmark of many pathologies. Fibril formation
is accompanied by oligomeric species thought to be the primary pathogenic
agents in many of these diseases. With the aim of identifying the
structural determinants responsible for the toxicity of misfolded
oligomers, we created 12 oligomeric variants from the N-terminal domain
of the <i>E. coli</i> HypF protein (HypF-N) by replacing
one or more charged amino acid residues with neutral apolar residues
and allowing the mutated proteins to aggregate under two sets of conditions.
The resulting oligomeric species have different degrees of cytotoxicity
when added to the extracellular medium of the cells, as assessed by
the extent of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction, apoptosis, and influx of Ca<sup>2+</sup> into
the cells. The structural properties of the oligomeric variants were
characterized by evaluating their surface hydrophobicity with 8-anilinonaphthalene-1-sulfonate
(ANS) binding and by measuring their size by means of turbidimetry
as well as light scattering. We find that increases in the surface
hydrophobicity of the oligomers following mutation can promote the
formation of larger assemblies and that the overall toxicity correlates
with a combination of both surface hydrophobicity and size, with the
most toxic oligomers having high hydrophobicity and small size. These
results have allowed the relationships between these three parameters
to be studied simultaneously and quantitatively, and have enabled
the generation of an equation that is able to rationalize and even
predict toxicity of the oligomers resulting from their surface hydrophobicity
and size
Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations
Living systems protect themselves from aberrant proteins by a network of chaperones. We have tested in vitro the effects of different concentrations, ranging from 0 to 16 μm, of two molecular chaperones, namely αB-crystallin and clusterin, and an engineered monomeric variant of transthyretin (M-TTR), on the morphology and cytotoxicity of preformed toxic oligomers of HypF-N, which represent a useful model of misfolded protein aggregates. Using atomic force microscopy imaging and static light scattering analysis, all were found to bind HypF-N oligomers and increase the size of the aggregates, to an extent that correlates with chaperone concentration. SDS-PAGE profiles have shown that the large aggregates were predominantly composed of the HypF-N protein. ANS fluorescence measurements show that the chaperone-induced clustering of HypF-N oligomers does not change the overall solvent exposure of hydrophobic residues on the surface of the oligomers. αB-crystallin, clusterin and M-TTR can diminish the cytotoxic effects of the HypF-N oligomers at all chaperone concentration, as demonstrated by MTT reduction and Ca2+ influx measurements. The observation that the protective effect is primarily at all concentrations of chaperones, both when the increase in HypF-N aggregate size is minimal and large, emphasizes the efficiency and versatility of these protein molecules
A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions
Oligomeric assemblies
of the amyloid β peptide (Aβ)
have been investigated for over two decades as possible neurotoxic
agents in Alzheimer’s disease. However, due to their heterogeneous
and transient nature, it is not yet fully established which of the
structural features of these oligomers may generate cellular damage.
Here, we study distinct oligomer species formed by Aβ40 (the
40-residue form of Aβ) in the presence of four different metal
ions (Al3+, Cu2+, Fe2+, and Zn2+) and show that they differ in their structure and toxicity
in human neuroblastoma cells. We then describe a correlation between
the size of the oligomers and their neurotoxic activity, which provides
a type of structure–toxicity relationship for these Aβ40
oligomer species. These results provide insight into the possible
role of metal ions in Alzheimer’s disease by the stabilization
of Aβ oligomers
Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers
The
formation of misfolded protein oligomers during early stages
of amyloid aggregation and the activation of neuroinflammatory responses
are two key events associated with neurodegenerative diseases. Although
it has been established that misfolded oligomers are involved in the
neuroinflammatory process, the links between their structural features
and their functional effects on the immune response remain unknown.
To explore such links, we took advantage of two structurally distinct
soluble oligomers (type A and B) of protein HypF-N and compared the
elicited microglial inflammatory responses. By using confocal microscopy,
protein pull-down, and high-throughput mass spectrometry, we found
that, even though both types bound to a common pool of microglial
proteins, type B oligomerswith a lower solvent-exposed hydrophobicityshowed
enhanced protein binding, correlating with the observed inflammatory
response. Furthermore, the interactome associated with inflammatory-mediated
neurodegeneration revealed previously unidentified receptors and signaling
molecules likely to be involved in the oligomer-elicited innate immune
response
Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers
The
formation of misfolded protein oligomers during early stages
of amyloid aggregation and the activation of neuroinflammatory responses
are two key events associated with neurodegenerative diseases. Although
it has been established that misfolded oligomers are involved in the
neuroinflammatory process, the links between their structural features
and their functional effects on the immune response remain unknown.
To explore such links, we took advantage of two structurally distinct
soluble oligomers (type A and B) of protein HypF-N and compared the
elicited microglial inflammatory responses. By using confocal microscopy,
protein pull-down, and high-throughput mass spectrometry, we found
that, even though both types bound to a common pool of microglial
proteins, type B oligomerswith a lower solvent-exposed hydrophobicityshowed
enhanced protein binding, correlating with the observed inflammatory
response. Furthermore, the interactome associated with inflammatory-mediated
neurodegeneration revealed previously unidentified receptors and signaling
molecules likely to be involved in the oligomer-elicited innate immune
response
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers
Chaperones are the primary regulators of the proteostasis network and are known to facilitate protein folding, inhibit protein aggregation, and promote disaggregation and clearance of misfolded aggregates inside cells. We have tested the effects of five chaperones on the toxicity of misfolded oligomers preformed from three different proteins added extracellularly to cultured cells. All the chaperones were found to decrease oligomer toxicity significantly, even at very low chaperone/protein molar ratios, provided that they were added extracellularly rather than being overexpressed in the cytosol. Infrared spectroscopy and site-directed labeling experiments using pyrene ruled out structural reorganizations within the discrete oligomers. Rather, confocal microscopy, SDS-PAGE, and intrinsic fluorescence measurements indicated tight binding between oligomers and chaperones. Moreover, atomic force microscopy imaging indicated that larger assemblies of oligomers are formed in the presence of the chaperones. This suggests that the chaperones bind to the oligomers and promote their assembly into larger species, with consequent shielding of the reactive surfaces and a decrease in their diffusional mobility. Overall, the data indicate a generic ability of chaperones to neutralize extracellular misfolded oligomers efficiently and reveal that further assembly of protein oligomers into larger species can be an effective strategy to neutralize such extracellular species
DataSheet1_Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates.pdf
The aggregation of the human islet amyloid polypeptide (IAPP) is associated with diabetes type II. A quantitative understanding of this connection at the molecular level requires that the aggregation mechanism of IAPP is resolved in terms of the underlying microscopic steps. Here we have systematically studied recombinant IAPP, with amidated C-terminus in oxidised form with a disulphide bond between residues 3 and 7, using thioflavin T fluorescence to monitor the formation of amyloid fibrils as a function of time and IAPP concentration. We used global kinetic analyses to connect the macroscopic measurements of aggregation to the microscopic mechanisms, and show that the generation of new aggregates is dominated by the secondary nucleation of monomers on the fibril surface. We then exposed insulinoma cells to aliquots extracted from different time points of the aggregation process, finding the highest toxicity at the midpoint of the reaction, when the secondary nucleation rate reaches its maximum. These results identify IAPP oligomers as the most cytotoxic species generated during IAPP aggregation, and suggest that compounds that target secondary nucleation of IAPP could be most effective as therapeutic candidates for diabetes type II.</p
